Breast Neoplasms, Quality of Life, Survivorship
Conditions
Keywords
Breast cancer, Quality of life, Survivorship, Survival, French West Indies
Brief summary
Cancer and its treatments can be factors that alter the quality of life of patients. The induced alteration of the quality of life can influence compliance and impact survival. Considering the after-effects of the treatment, carrying out such a survey will provide for the first time precise information on the main determinants of the quality of life as well as on the care pathway of patients with invasive breast cancer in the Martinique region.
Detailed description
Breast cancer is the second most common cancer in the West Indies and the leading cancer in women. With 215 new cases in Guadeloupe, 204 in Martinique and 56 in French Guiana each year, it accounts for 37%, 33% and 26% of incident cancer cases in women respectively, but also affects men. Its incidence, lower than in France, is increasing over the period 2008-2014. The diagnostic and therapeutic management of cancer can have an impact on the quality of life of patients, taking into account the adverse effects occurring during and after treatment, both in the short and long term. The European Organisation for Research and Treatment of Cancer (EORTC) has developed a series of questionnaires to assess the quality of life of cancer patients, including a general questionnaire (QLQ-C30) and specific modules for breast cancer (EORTC BREAST (EORTC QLQ-BR23)) with the objective of improving professional practices.
Interventions
OTHERQuality of life questionnaires
Patients' quality of life will be assessed with self-reported items through both the EORTC-QLQ-C30 and EORTC-QLQ-BR23 modules.
Sponsors
University Hospital Center of Martinique
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient over 18 years of age residing in Martinique with invasive breast cancer diagnosed from 2020 (single tumor at diagnosis) * Patients who have read the information note and have indicated that they do not wish to participate in the study * Patient with social security coverage.
Exclusion criteria
* Refusal to participate * Patient with insitu breast cancer * Patient with a second cancer * Patient with cancer within 5 years prior to inclusion * Patient who could not answer quality of life questionnaires * Patient not fluent in French * Person under legal protection (safeguard of justice, guardianship, curators , etc.).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of global disorders in patients with breast cancer | 12 months after diagnosis | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-C30 |
| Assessment of disorders specific to breast cancer patients Assessment of disorders specific to breast cancer patients | 12 months after diagnosis | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-BR23 |
| Assessment of disorders specific to breast cancer patients | 36 months after diagnosis | Quality of life of patients with invasive breast cancer in Martinique assessed by QLQ-BR23 |
Countries
Martinique
Contacts
PRINCIPAL_INVESTIGATORClarisse JOACHIM-CONTARET
CHU Martinique
Outcome results
None listed